4//SEC Filing
Hordo Christian 4
Accession 0001562180-21-005916
CIK 0001770121other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 7:27 PM ET
Size
11.2 KB
Accession
0001562180-21-005916
Insider Transaction Report
Form 4
Hordo Christian
SVP, Chief Business Officer
Transactions
- Sale
Common Stock
2021-09-09$25.01/sh−25,466$636,856→ 943,932 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-09−39,205→ 88,803 totalExercise: $1.48Exp: 2030-01-26→ Common Stock (39,205 underlying) - Exercise/Conversion
Common Stock
2021-09-09$1.48/sh+39,205$58,023→ 1,008,603 total - Sale
Common Stock
2021-09-09$25.01/sh−39,205$980,635→ 969,398 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.18, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive.
- [F4]This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001830070
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 7:27 PM ET
- Size
- 11.2 KB